PF-00299804
Drug timelines are a Plus or Pro feature.
16 regulatory and trial events tracked for PF-00299804, covering 2010-01-07 to 2021-02-09. Get the full timeline:
Most recent: Clinical Trial Update: Open-Label Trial Of Oral PF-00299804 By Continuous Dosing In Patients With Recurrent Or Metastatic Head And Neck Squamous Cell Cancer [Phase 2]